Skip to main content
MedPathMedPath Home
Clinical Trials/NCT05440188
NCT05440188
Completed
Not Applicable

Identification of the Reduction of Exacerbations Resulting in Hospital Admission in COPD Patients After the Use of the Breath Detect Telemedicine Platform.

Universidad Autonoma de Madrid1 site in 1 country80 target enrollmentOctober 1, 2022
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsCOPD Exacerbation

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
COPD Exacerbation
Sponsor
Universidad Autonoma de Madrid
Enrollment
80
Locations
1
Primary Endpoint
Number of hospital admissions due to exacerbations
Status
Completed
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

identification of the reduction of exacerbations resulting in hospital admission in COPD patients after the use of the Breath Detect telemedicine platform.

Registry
clinicaltrials.gov
Start Date
October 1, 2022
End Date
October 23, 2023
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Raúl Ferrer-Peña

Principal Investigator

Universidad Autonoma de Madrid

Eligibility Criteria

Inclusion Criteria

  • •COPD diagnosed in GOLD II state or higher

Exclusion Criteria

  • •Can´t read and talk in spanish

Outcomes

Primary Outcomes

Number of hospital admissions due to exacerbations

Time Frame: 24 weeks

Study Sites (1)

Loading locations...

Similar Trials

Completed
Phase 4
Evaluating the Control of COPD Symptoms in Patients Treated With Tiotropium Bromide 18mcg Once Daily Alone, ADOAIR 50/250mcg Twice Daily Alone or ADOAIR 50/250mcg Plus Tiotropium Bromide 18mcgPulmonary Disease, Chronic Obstructive
NCT01762800GlaxoSmithKline407
Completed
Not Applicable
Cough Frequency in Chronic Obstructive Pulmonary DiseaseCOPD Exacerbation
NCT01405222Hull University Teaching Hospitals NHS Trust24
Completed
Not Applicable
Treatment of exacerbations of COPD: a co-operation between primary health care and hospital care. A prospective, randomized trial.
NL-OMON28120128
Active, not recruiting
Not Applicable
Exacerbation Prevention in chronic obstructive pulmonary disease (COPD) - using High Flow Therapy at home to reduce hospital readmission (EPIC-HFT UK)
ISRCTN89405844Guy's and St Thomas' NHS Foundation Trust502
Completed
Not Applicable
Exacerbation and Training in Patients With Chronic Obstructive Pulmonary DiseaseCOPD
NCT00877084KU Leuven40